Muriel X.G. Draht

1.0k total citations · 1 hit paper
9 papers, 691 citations indexed

About

Muriel X.G. Draht is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Muriel X.G. Draht has authored 9 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Muriel X.G. Draht's work include Epigenetics and DNA Methylation (6 papers), Genetic factors in colorectal cancer (5 papers) and RNA modifications and cancer (3 papers). Muriel X.G. Draht is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genetic factors in colorectal cancer (5 papers) and RNA modifications and cancer (3 papers). Muriel X.G. Draht collaborates with scholars based in Netherlands, United States and France. Muriel X.G. Draht's co-authors include Veerle Melotte, Manon van Engeland, James G. Herman, Kim M. Smits, Alexander Koch, Tim De Meyer, Leander Van Neste, Tim C. de Ruijter, Wim Van Criekinge and Zheng Feng and has published in prestigious journals such as Clinical Cancer Research, Nature Reviews Clinical Oncology and Molecular Oncology.

In The Last Decade

Muriel X.G. Draht

9 papers receiving 687 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of DNA methylation in cancer: location revisited

2018 491 citations Alexander Koch, Sophie C. Joosten et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muriel X.G. Draht Netherlands	8	551	231	170	134	76	9	691
Fujun Zhao China	14	442 0.8×	243 1.1×	153 0.9×	97 0.7×	31 0.4×	38	683
Maira M. Pires United States	8	409 0.7×	229 1.0×	290 1.7×	145 1.1×	39 0.5×	11	621
Sophie C. Joosten Netherlands	7	675 1.2×	274 1.2×	337 2.0×	126 0.9×	30 0.4×	8	835
Janet I. Lee United States	8	502 0.9×	104 0.5×	168 1.0×	191 1.4×	68 0.9×	8	636
Romina Sepe Italy	17	666 1.2×	381 1.6×	95 0.6×	134 1.0×	49 0.6×	26	835
Wai Kei Kwok Hong Kong	6	504 0.9×	230 1.0×	124 0.7×	279 2.1×	42 0.6×	6	702
Jeffrey C. Francis United Kingdom	10	423 0.8×	104 0.5×	141 0.8×	190 1.4×	120 1.6×	14	561
Warwick J. Locke Australia	11	604 1.1×	283 1.2×	139 0.8×	128 1.0×	28 0.4×	13	773
Makiko Sakata Japan	16	427 0.8×	122 0.5×	73 0.4×	199 1.5×	107 1.4×	30	582
Nuno Cerveira Portugal	14	379 0.7×	183 0.8×	289 1.7×	110 0.8×	66 0.9×	38	687

Countries citing papers authored by Muriel X.G. Draht

Since Specialization

Citations

This map shows the geographic impact of Muriel X.G. Draht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel X.G. Draht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel X.G. Draht more than expected).

Fields of papers citing papers by Muriel X.G. Draht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel X.G. Draht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel X.G. Draht. The network helps show where Muriel X.G. Draht may publish in the future.

Co-authorship network of co-authors of Muriel X.G. Draht

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel X.G. Draht. A scholar is included among the top collaborators of Muriel X.G. Draht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel X.G. Draht. Muriel X.G. Draht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Koch, Alexander, Muriel X.G. Draht, Kristien Wouters, et al.. (2021). Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. Clinical Epigenetics. 13(1). 80–80. 25 indexed citations

2.

Draht, Muriel X.G., Alexander Koch, Heike I. Grabsch, et al.. (2018). Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clinical Epigenetics. 10(1). 35–35. 34 indexed citations

3.

Koch, Alexander, Sophie C. Joosten, Zheng Feng, et al.. (2018). Analysis of DNA methylation in cancer: location revisited. Nature Reviews Clinical Oncology. 15(7). 459–466. 491 indexed citations breakdown →

4.

Koch, Alexander, Sophie C. Joosten, Zheng Feng, et al.. (2018). Author Correction: Analysis of DNA methylation in cancer: location revisited. Nature Reviews Clinical Oncology. 15(7). 467–467. 29 indexed citations

5.

Draht, Muriel X.G., Kim M. Smits, Valérie Jooste, et al.. (2016). Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome. Clinical Epigenetics. 8(1). 44–44. 19 indexed citations

6.

Draht, Muriel X.G., Kim M. Smits, Caroline Chapusot, et al.. (2016). Additional file 1: Table S1. of Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome. 1 indexed citations

7.

Cleven, Arjen H.G., Sarah Derks, Muriel X.G. Draht, et al.. (2014). CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 20(12). 3261–3271. 30 indexed citations

8.

Draht, Muriel X.G., Kim M. Smits, Valérie Jooste, et al.. (2014). Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. Molecular Oncology. 8(3). 679–688. 30 indexed citations

9.

Draht, Muriel X.G., Hanneke E.C. Niessen, Beatriz Carvalho, et al.. (2012). Promoter CpG Island Methylation Markers in Colorectal Cancer: The Road Ahead. Epigenomics. 4(2). 179–194. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact